Market Research Logo

Malignant Pleural Effusion - Pipeline Review, H2 2018

Malignant Pleural Effusion - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malignant Pleural Effusion - Pipeline Review, H2 2018, provides an overview of th


Introduction
Global Markets Direct Report Coverage
Malignant Pleural Effusion - Overview
Malignant Pleural Effusion - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Malignant Pleural Effusion - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Malignant Pleural Effusion - Companies Involved in Therapeutics Development
Advantagene Inc
Amgen Inc
Biogen Inc
Genelux Corp
Malignant Pleural Effusion - Drug Profiles
BG-00001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy for Malignant Pleural Effusion and Solid Tumors - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy to Activate p53 for Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GLONC-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
methotrexate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PTS-500 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
talimogene laherparepvec - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Malignant Pleural Effusion - Dormant Projects
Malignant Pleural Effusion - Product Development Milestones
Featured News & Press Releases
May 12, 2015: Genelux to Present Posters Supporting Lead Oncolytic Viral Therapy GL-ONC1 at ASCO Annual Meeting 2015
Jun 15, 2013: Genelux Presents Abstracts at the 7th International Meeting on Replicating Oncolytic Virus Therapeutics in Quebec
May 30, 2013: Genelux To Present Abstracts For Clinical Trials Of Oncolytic Viral Therapy GL-ONC1 At 2013 ASCO Annual Meeting
Feb 06, 2013: Genelux Announces Treatment Of First Patient In Phase I Trial With GL-ONC1 At Memorial Sloan Kettering Cancer Center
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Malignant Pleural Effusion, H2 2018
Number of Products under Development by Companies, H2 2018
Products under Development by Companies, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Malignant Pleural Effusion - Pipeline by Advantagene Inc, H2 2018
Malignant Pleural Effusion - Pipeline by Amgen Inc, H2 2018
Malignant Pleural Effusion - Pipeline by Biogen Inc, H2 2018
Malignant Pleural Effusion - Pipeline by Genelux Corp, H2 2018
Malignant Pleural Effusion - Dormant Projects, H2 2018
List of Figures
Number of Products under Development for Malignant Pleural Effusion, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Targets, H2 2018
Number of Products by Stage and Targets, H2 2018
Number of Products by Mechanism of Actions, H2 2018
Number of Products by Stage and Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report